Roche stock falls after breast cancer combo therapy fails in trial
Source: SeekingAlpha
2026-03-09 06:21:00 ET
More on Roche Holding, Pfizer
- Pfizer: Obesity Hype And Vaccine Policy Shocks
- Pfizer's Portfolio Renewal In Progress - High Yields For The Patient
- Pfizer's Quiet Cash Comeback
- Roche continues to expect tariff impact on diagnostics despite U.S. deal
- FDA vaccine chief to leave the agency again
Read the full article on Seeking Alpha
For further details see:
Roche stock falls after breast cancer combo therapy fails in trial
Roche Holding Ltd
NASDAQ: RHHBF
RHHBF Trading
-6.23% G/L:
$436.044 Last:
31 Volume:
$411.36 Open:
RHHBF Latest News
RHHBF Stock Data
$362,551,633,888
800,578,845
N/A
474
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
